Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasisSun Lee, Won‐Yoon Chung, Kwang-Kyun Park et al.|Scientific Reports|2017Cited by 71
Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatmentSe Young Park, Won‐Yoon Chung, Hyun‐Jeong Kim et al.|Toxicology and Applied Pharmacology|2014Cited by 46
Loss of <scp>RUNX3</scp> expression promotes cancer‐associated bone destruction by regulating <scp>CCL5</scp>, <scp>CCL19</scp> and <scp>CXCL11</scp> in non‐small cell lung cancerHyun‐Jeong Kim, Won‐Yoon Chung, Junhee Park et al.|The Journal of Pathology|2015Cited by 45
Artemisia annua extract prevents ovariectomy-induced bone loss by blocking receptor activator of nuclear factor kappa-B ligand-induced differentiation of osteoclastsSun Lee, Won‐Yoon Chung, Hyungkeun Kim et al.|Scientific Reports|2017Cited by 35
15-Deoxy-Δ12,14-Prostaglandin J2 Inhibits Osteolytic Breast Cancer Bone Metastasis and Estrogen Deficiency-Induced Bone LossKi‐Rim Kim, Won‐Yoon Chung, Hyun‐Jeong Kim et al.|PLoS ONE|2015Cited by 29